Tempus AI Long-term Debt / Capital 2023-2025 | TEM
Current and historical long-term debt / capital for Tempus AI (TEM) from 2023 to 2025. Long-term debt / capital can be defined as a measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Tempus AI long-term debt / capital for the three months ending March 31, 2025 was 0.71.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.820B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.022B | 58.55 |
| Doximity (DOCS) | United States | $11.014B | 50.99 |
| Hims & Hers Health (HIMS) | United States | $9.614B | 99.88 |
| IRhythm Technologies (IRTC) | United States | $4.905B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.910B | 61.09 |
| Hinge Health (HNGE) | United States | $3.661B | 0.00 |
| Privia Health (PRVA) | United States | $2.683B | 183.42 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.658B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.445B | 0.00 |
| Azenta (AZTA) | United States | $1.378B | 64.06 |
| Omnicell (OMCL) | United States | $1.363B | 24.05 |
| 10x Genomics (TXG) | United States | $1.341B | 0.00 |
| Evolent Health (EVH) | United States | $1.247B | 106.20 |
| Claritev (CTEV) | United States | $0.667B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.594B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.497B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.480B | 143.50 |
| Standard BioTools (LAB) | United States | $0.463B | 0.00 |
| Outset Medical (OM) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.346B | 768.33 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.210B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.109B | 4.15 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| 111 (YI) | China | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.043B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.043B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |